Cantourage Group SE | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Cantourage Group SE

BRIEF

published on 10/01/2025 at 09:52, 2 months 3 days ago

Cantourage Strengthens European Capital Markets Strategy

Investor Relations Capital Markets Strategic Focus Medical Cannabis European Markets
PRESS RELEASE

published on 10/01/2025 at 09:47, 2 months 3 days ago

Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe
Cantourage Group SE strengthens capital markets presence with new Head of Investor Relations focusing on Europe. Appointment of Manuel Taverne underscores commitment to enhancing investor engagement

Investor Relations Europe Capital Markets Cantourage Group SE Manuel Taverne
BRIEF

published on 09/05/2025 at 09:05, 2 months 29 days ago

Cantourage's Strategic Maneuvers Amid Regulatory Uncertainty

International Expansion Cantourage Group SE CEO Return Regulatory Uncertainty Germany Market Strategy
PRESS RELEASE

published on 09/05/2025 at 09:00, 2 months 29 days ago

Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE to expand in Germany, UK, and Poland amidst regulatory uncertainties. CEO's return key to navigating challenges. Stock rating updated to BUY with target price of EUR 10.50

Expansion Cantourage Group SE Stock Rating CEO Return Regulatory Uncertainties
BRIEF

published on 07/11/2025 at 09:05, 4 months 24 days ago

Cantourage Group SE: Robust Performance and Strategic Adjustments

CEO Transition Sales Growth Investment Recommendation Cantourage Group Telemedicine Regulation
PRESS RELEASE

published on 07/11/2025 at 09:00, 4 months 24 days ago

Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE continues strong operations with CEO on temporary leave. Q2 sales up 158% yoy, exceeding H1 sales of €53.5m. New interim CEO appointed. Share price considered undervalued, with BUY rating reaffirmed

Interim CEO Sales Increase Cantourage Group SE Undervalued Shares CEO Leave
BRIEF

published on 05/20/2025 at 07:56, 6 months 15 days ago

Cantourage Reports Strong Growth in Q1 2025

Revenue Growth EBITDA Margin International Market Medical Cannabis Operational Profitability
PRESS RELEASE

published on 05/20/2025 at 07:51, 6 months 15 days ago

Cantourage achieves strong and profitable growth in the first quarter of 2025
Cantourage Group SE achieves strong and profitable growth in Q1 2025 with EUR 25 million revenue and 11-13% EBITDA margin, continuing rapid expansion

Medical Cannabis Cantourage Group SE Profitable Q1 2025 Strong Growth
BRIEF

published on 05/20/2025 at 07:51, 6 months 15 days ago

Cantourage Reports Strong Q1 2025 Earnings with Boosted Profitability

European Market EBITDA Margin Medical Cannabis Cantourage Group Q1 2025 Profitability
PRESS RELEASE

published on 05/20/2025 at 07:46, 6 months 15 days ago

EQS-Adhoc: Ad hoc: Cantourage significantly increases profitability and revenue – EBITDA margin of 11 to 13% in the first quarter of 2025
Cantourage Group SE reports a significant increase in profitability and revenue with an EBITDA margin of 11 to 13% in the first quarter of 2025. Revenue exceeds EUR 25 million

Revenue Profitability EBITDA Margin Medical Cannabis Cantourage Group SE

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 39 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 38 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 43 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE